Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.42 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.42 |
| ▸ | FABP4 | P15090 | 3/20 | 0.41 |
| ▸ | FABP3 | P05413 | 2/20 | 0.41 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3192221 | 0.84 | GABRA1 (0.43) | GABRA1GABRB2FABP4FABP3FABP5 | |
| SCHEMBL31502507 | 0.77 | GABRA1 (0.48) | GABRA1GABRB2FABP4FABP3FABP5 | |
| SCHEMBL915884 | 0.77 | GABRA1 (0.48) | GABRA1GABRB2FABP4FABP3FABP5 | |
| SCHEMBL3189037 | 0.76 | GABRA1 (0.44) | GABRA1GABRB2 | |
| SCHEMBL8884997 | 0.75 | GABRA1 (0.46) | GABRA1GABRB2FABP4FABP3FABP5 | |
| SCHEMBL17125433 | 0.73 | GABRA1 (0.50) | GABRA1GABRB2FABP4FABP3FABP5 | |
| SCHEMBL28111265 | 0.73 | GABRA1 (0.45) | GABRA1GABRB2FABP4FABP3FABP5 | |
| SCHEMBL21415476 | 0.73 | GABRA1 (0.45) | GABRA1GABRB2FABP4FABP3FABP5 | |
| SCHEMBL8884992 | 0.73 | GABRA1 (0.45) | GABRA1GABRB2FABP4FABP3FABP5 | |
| SCHEMBL6063410 | 0.73 | GABRA1 (0.45) | GABRA1GABRB2FABP4FABP3FABP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2133357-B1 | LIVING RADICAL POLYMERIZATION PROMOTER | OTSUKA CHEMICAL CO LTD (JP) | 2016-11-16 | — | — | EP | disclosed |
| US-8076430-B2 | Living radical polymerization promoter | OTSUKA CHEMICAL CO., LTD. (JP) | 2011-12-13 | — | — | US | disclosed |
| US-20100022728-A1 | LIVING RADICAL POLYMERIZATION PROMOTER | OTSUKA CHEMICAL CO., LTD. (JP) | 2010-01-28 | — | — | US | disclosed |
| EP-2133357-A1 | LIVING RADICAL POLYMERIZATION PROMOTER | Otsuka Chemical Holdings Co., Ltd. (JP) | 2009-12-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100022728-A1 | LIVING RADICAL POLYMERIZATION PROMOTER | DNMT1, CYP1B1, DNMT3B | GABRA1 3794/4885GABRB2 2846/4885FABP4 4028/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.